Butorphanol Alleviates Hypoxia/Reoxygenation‐Induced Myocardial Injury by Activating Wnt/β‐Catenin Signal Pathway
Journal of Applied Toxicology · 2025
DOI: 10.1002/jat.4736 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Applied Toxicology, 2025. Verfasst von Shi-Rui Hao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, First Hospital Affiliated of Jinzhou Medical University, Jinzhou, Liaoning, China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Butorphanol, Myocardial Reperfusion Injury, Cardiotonic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province.
Abstract (Originalsprache)
Ischemic heart disease remains a global health problem with high morbidity and mortality. Butorphanol, as a novel opioid, has been discovered with its cardioprotective properties. The purpose of this study was to explore that butorphanol can alleviate hypoxia/reoxygenation (H/R)‐induced myocardial injury by activating the Wnt/β‐catenin signal pathway. In this study, Cell Counting Kit‐8 (CCK‐8), lactate dehydrogenase (LDH) kit, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, and Western blotting experiments were performed to observe butorphanol cardioprotective function and expression of Wnt signaling pathway proteins. For the main result, anti‐apoptotic effect and higher expression of Wnt signaling pathway proteins were observed with the increasing concentrations of butorphanol. Compared with the H/R group, higher cellular viability, lower LDH release, and smaller apoptotic cell population were found in the butorphanol group. In addition, expression levels of apoptosis‐related protein Bax and Cleaved Caspase‐3 decreased, and increased expression of Bcl‐2 were observed. Conversely, the protective effects of butorphanol were attenuated in the XAV939 group. In summary, butorphanol attenuates hypoxia/reoxygenation‐induced myocardial injury by activating the Wnt/β‐catenin signal pathway. Our work provides a theoretical basis for butorphanol's myocardial protective function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, First Hospital Affiliated of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Second Outpatient Department of Traditional Chinese Medicine, First Hospital Affiliated of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Thyroid Surgery, First Hospital Affiliated of Jinzhou Medical University, Jinzhou, Liaoning, China.
- Department of Emergency Surgery, First Hospital Affiliated of Jinzhou Medical University, Jinzhou, Liaoning, China.
ORCID-Profile: Qiao-Ling Wu
Förderung
- Natural Science Foundation of Liaoning Province
Zitieren
APA
Hao, S. R., Xie, Z. F., Li, J. X., Wang, Q. Z., Wu, T. T., Shen, T., & Wu, Q. L. (2025). Butorphanol Alleviates Hypoxia/Reoxygenation‐Induced Myocardial Injury by Activating Wnt/β‐Catenin Signal Pathway. Journal of Applied Toxicology. https://doi.org/10.1002/jat.4736
Vancouver
Hao SR, Xie ZF, Li JX, Wang QZ, Wu TT, Shen T, et al. Butorphanol Alleviates Hypoxia/Reoxygenation‐Induced Myocardial Injury by Activating Wnt/β‐Catenin Signal Pathway. Journal of Applied Toxicology. 2025. doi:10.1002/jat.4736
BibTeX
@article{Hao2025,
author = {Hao, Shi-Rui and Xie, Zi-Feng and Li, Jia-Xin and Wang, Qin-Zhi and Wu, Ting-Ting and Shen, Tu and Wu, Qiao-Ling},
title = {Butorphanol Alleviates Hypoxia/Reoxygenation‐Induced Myocardial Injury by Activating Wnt/β‐Catenin Signal Pathway},
journal = {Journal of Applied Toxicology},
year = {2025},
doi = {10.1002/jat.4736}
}
EUVIMED